Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immunometabolic mechanisms of ionizing radiation in a mouse model of gastrointestinal acute radiation syndrome.

International journal of radiation biology·2026

Same author

Editorial: Mechanistic and statistical modeling approaches to study alloimmune T-cell responses.

Frontiers in immunology·2025

Same author

The TITAN-X Platform Integrates Big Data, Artificial Intelligence, Bioinformatics, and Advanced Computational Modeling to Understand Immune Responses and Develop the Next Wave of Precision Medicines.

Annual review of biomedical data science·2025

Same author

Safety, Tolerability, and Pharmacokinetics of NIM-1324 an Oral LANCL2 Agonist in a Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial.

Clinical and translational science·2025

Same author

Immunometabolic Mechanisms of LANCL2 in CD4+ T Cells and Phagocytes Provide Protection from Systemic Lupus Erythematosus.

Journal of immunology (Baltimore, Md. : 1950)·2024

Same author

Treating Autoimmune Diseases With LANCL2 Therapeutics: A Novel Immunoregulatory Mechanism for Patients With Ulcerative Colitis and Crohn's Disease.

Inflammatory bowel diseases·2023

Same journal

Latest Advances in Obesity Treatment by Regulating Adipocyte Thermogenesis.

PPAR research·2026

Same journal

Metabolic Reprogramming and Immune Metabolism in Sepsis: Targeting the PPAR Pathway for Personalized Therapeutic Approaches.

PPAR research·2026

Same journal

Mediating Role of Muscle Mass in the Relationship Between Physical Activity and Bone Mass in Female University Students in China.

PPAR research·2026

Same journal

Correction to "Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy During Hepatic Ischemia-Reperfusion Injury by Modulating JAK2/STAT3<i>β</i>/PPAR<i>α</i> Pathway".

PPAR research·2026

Same journal

The Mechanistic Role of PPAR<i>γ</i> in Wound Healing.

PPAR research·2026

Same journal

To Explore the Active Components, Targets, and Potential Effects of Emodin in the Treatment of Colorectal Cancer Based on Network Pharmacology.

PPAR research·2025

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Virtual Screening as a Technique for PPAR Modulator Discovery.

Stephanie N Lewis¹, Josep Bassaganya-Riera, David R Bevan

¹Genetics, Bioinformatics, and Computational Biology Program, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.

|September 12, 2009

Summary

This summary is machine-generated.

Virtual screening identifies new compounds for diseases. This study focuses on discovering peroxisome proliferator-activated receptor-gamma (PPARgamma) agonists using computational methods for potential anti-inflammatory and diabetes treatments.

More Related Videos

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Related Experiment Videos

Last Updated: Jun 20, 2026

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Area of Science:

Computational chemistry
Pharmacology
Drug discovery

Background:

Virtual screening (VS) is a key technique for identifying novel therapeutic compounds.
Peroxisome proliferator-activated receptor-gamma (PPARgamma) agonists show promise for type 2 diabetes and inflammation.
PPARgamma agonists are valuable therapeutic agents.

Purpose of the Study:

To explore in silico screening for novel peroxisome proliferator-activated receptor-gamma (PPARgamma) agonists.
To develop computational methods for assessing PPARgamma-binding activity in large compound libraries.
To advance the understanding of PPARgamma biology and develop immunotherapeutics.

Main Methods:

In silico screening of compound libraries.
Computational approaches for predicting PPARgamma-binding activity.
Review of virtual screening processes for immunotherapeutics.

Main Results:

Virtual screening offers a cost- and time-effective approach to drug discovery.
Computational methods can prioritize compounds for experimental validation.
This approach has high potential for understanding PPARgamma biology.

Conclusions:

Computational screening, combined with experimental validation, can accelerate the discovery of PPARgamma agonists.
This strategy can lead to novel therapies for chronic inflammatory diseases.
Further development of computational screening processes is crucial for advancing immunotherapeutics.